Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: aatkinson who wrote (1482)	2/24/1998 12:10:00 PM
From: Sigmund	Read Replies (1) \| Respond to of 1894

I thought of that. This way the preferred stock certainly isn't callable or probably not even able to be recalled or converted at the company's option. I imagine that some pressure was put on these bond holders since 12% is nice if you think it will be paid and the principal is safe. It is tricky to figure out how to assess this move other than the obvious point that it helps to preserve a NASDAQ listing. Will the preferred stock and warrants be registered and traded? If so, it will be interesting to see what value the market places on the warrants.